Financials data is unavailable for this security.
View more
Year on year Beijing Succeeder Technology Inc grew revenues 20.40% from 228.81m to 275.49m while net income improved 12.29% from 104.11m to 116.91m.
| Gross margin | 60.39% |
|---|---|
| Net profit margin | 37.85% |
| Operating margin | 43.15% |
| Return on assets | 6.69% |
|---|---|
| Return on equity | 7.03% |
| Return on investment | 7.02% |
More ▼
Cash flow in CNYView more
In 2023, Beijing Succeeder Technology Inc did not generate a significant amount of cash. However, the company earned 109.64m from its operations for a Cash Flow Margin of 39.80%. In addition the company used 100.72m on investing activities and also paid 22.04m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 15.41 |
|---|---|
| Tangible book value per share | 15.19 |
More ▼
Balance sheet in CNYView more
| Current ratio | 15.29 |
|---|---|
| Quick ratio | 14.78 |
| Total debt/total equity | 0.00004 |
|---|---|
| Total debt/total capital | 0.00004 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 30.00% and 12.29%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 24.48% |
| EPS growth(5 years) | 7.44 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -1.31 |
More ▼
